Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980453917> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W2980453917 endingPage "7" @default.
- W2980453917 startingPage "1" @default.
- W2980453917 abstract "Introduction: Fosfomycin an antibiotic having unique chemical structure possess broad-spectrum activity against numerous pathogenic organisms including both gram negative and gram positive bacteria including multi-resistant strains. In early 1970 this antibiotic was accepted in clinical practice, but for several years the use of fosfomycin was limited for treating uncomplicated lower urinary tract infections. However, fosfomycin achieves clinically relative concentrations in serum, cerebrospinal fluid, other body fluids, lung, kidney, bladder wall, prostate gland, heart valve tissues, other inflamed tissues, abscess, and bone as well and has shown the good activity in treating severe infections caused by multi-resistant pathogens at various body sites. The objective of the study was to evaluate fosfomycin as an alternative treatment against methicillin-resistant Staphylococcus aureus (MRSA) in a tertiary care hospital.
 Materials and Methods: The Prospective Descriptive cross-sectional study was conducted at the Department of Clinical Microbiology Laboratory at the Sindh Institute of Urology and Transplantation (SIUT) Hospital, Karachi, June 2017 till January 2018. A total of 147 specimens were collected from various body sites include blood, fluids like pleural fluid, synovial fluids, broncho-alveolar lavage, urine, pus and tissues were identified to genus level by a routine biochemical test. Antimicrobial sensitivity was determined by Kirby-Bauer disk diffusion method. All fosfomycin susceptible isolates i.e. Zone size of ≥16 mm and resistant isolates as zone size <16 mm were evaluated.
 Results: Out of 147 isolates 113 (76.9%) isolates were from blood, 12 (8.2%) were from other body fluids, 14(5%) were from pus and 8 (4%) from Urine. All 147 isolates were resistant to methicillin. Out of 147 isolates of MRSA 143(97.3%) were sensitive to fosfomycin and only 4 (2.7%) were found to be resistant.
 Conclusion: Fosfomycin proved to be a very good alternative for treating MRSA because of good activity against this pathogen as well as good penetration of fosfomycin in serum; tissues, cerebrospinal fluid and other body fluids make this drug effective in treating infections at various body sites." @default.
- W2980453917 created "2019-10-25" @default.
- W2980453917 creator A5009139062 @default.
- W2980453917 creator A5034764936 @default.
- W2980453917 creator A5037761126 @default.
- W2980453917 creator A5057434014 @default.
- W2980453917 creator A5087456636 @default.
- W2980453917 creator A5089314823 @default.
- W2980453917 date "2019-06-11" @default.
- W2980453917 modified "2023-09-26" @default.
- W2980453917 title "Fosfomycin an Alternative for the Treatment of Methicillin Resistant Staphylococcus aureus (MRSA)" @default.
- W2980453917 doi "https://doi.org/10.9734/sajrm/2019/v3i430098" @default.
- W2980453917 hasPublicationYear "2019" @default.
- W2980453917 type Work @default.
- W2980453917 sameAs 2980453917 @default.
- W2980453917 citedByCount "0" @default.
- W2980453917 crossrefType "journal-article" @default.
- W2980453917 hasAuthorship W2980453917A5009139062 @default.
- W2980453917 hasAuthorship W2980453917A5034764936 @default.
- W2980453917 hasAuthorship W2980453917A5037761126 @default.
- W2980453917 hasAuthorship W2980453917A5057434014 @default.
- W2980453917 hasAuthorship W2980453917A5087456636 @default.
- W2980453917 hasAuthorship W2980453917A5089314823 @default.
- W2980453917 hasBestOaLocation W29804539171 @default.
- W2980453917 hasConcept C126322002 @default.
- W2980453917 hasConcept C2777052132 @default.
- W2980453917 hasConcept C2778897966 @default.
- W2980453917 hasConcept C2779489039 @default.
- W2980453917 hasConcept C4937899 @default.
- W2980453917 hasConcept C501593827 @default.
- W2980453917 hasConcept C523546767 @default.
- W2980453917 hasConcept C54355233 @default.
- W2980453917 hasConcept C71924100 @default.
- W2980453917 hasConcept C86803240 @default.
- W2980453917 hasConcept C89423630 @default.
- W2980453917 hasConcept C94665300 @default.
- W2980453917 hasConceptScore W2980453917C126322002 @default.
- W2980453917 hasConceptScore W2980453917C2777052132 @default.
- W2980453917 hasConceptScore W2980453917C2778897966 @default.
- W2980453917 hasConceptScore W2980453917C2779489039 @default.
- W2980453917 hasConceptScore W2980453917C4937899 @default.
- W2980453917 hasConceptScore W2980453917C501593827 @default.
- W2980453917 hasConceptScore W2980453917C523546767 @default.
- W2980453917 hasConceptScore W2980453917C54355233 @default.
- W2980453917 hasConceptScore W2980453917C71924100 @default.
- W2980453917 hasConceptScore W2980453917C86803240 @default.
- W2980453917 hasConceptScore W2980453917C89423630 @default.
- W2980453917 hasConceptScore W2980453917C94665300 @default.
- W2980453917 hasLocation W29804539171 @default.
- W2980453917 hasOpenAccess W2980453917 @default.
- W2980453917 hasPrimaryLocation W29804539171 @default.
- W2980453917 hasRelatedWork W1966479678 @default.
- W2980453917 hasRelatedWork W1982642726 @default.
- W2980453917 hasRelatedWork W2083048030 @default.
- W2980453917 hasRelatedWork W2102251677 @default.
- W2980453917 hasRelatedWork W2326830576 @default.
- W2980453917 hasRelatedWork W2755377931 @default.
- W2980453917 hasRelatedWork W3199801895 @default.
- W2980453917 hasRelatedWork W4236456929 @default.
- W2980453917 hasRelatedWork W4366783445 @default.
- W2980453917 hasRelatedWork W2185011808 @default.
- W2980453917 isParatext "false" @default.
- W2980453917 isRetracted "false" @default.
- W2980453917 magId "2980453917" @default.
- W2980453917 workType "article" @default.